Filing Analysis
Hyperfine, Inc. filed an 8-K to announce its second quarter financial results for the period ended June 30, 2026, and provided a general business update via a press release.
📋 Key Facts
- Reporting date: August 06, 2026
- Period covered: Second Quarter ended June 30, 2026
- The filing includes a press release (Exhibit 99.1) containing results of operations and financial condition.
- Company is an emerging growth company.
Hyperfine, Inc. held its 2026 annual meeting of stockholders on May 21, 2026. Stockholders re-elected five directors to the Board and ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
📋 Key Facts
- The annual meeting of stockholders was held on May 21, 2026, with approximately 89.89% of the total voting power represented in person or by proxy.
- Stockholders held Class A common stock (1 vote per share) and Class B common stock (20 votes per share) as of the March 25, 2026 record date.
- Five directors (Daniel J. Wolterman, Maria Sainz, John Dahldorf, Ruth Fattori, and Jonathan M. Rothberg, Ph.D.) were re-elected to serve until the 2027 annual meeting.
- The appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified with 341,824,976 votes in favor.
Hyperfine, Inc. reported its financial results for the first quarter ended March 31, 2026, and provided a business update. The disclosure was made via a press release furnished as an exhibit to the 8-K filing.
📋 Key Facts
- The company announced Q1 2026 financial results on May 12, 2026.
- The reporting period for the results ended March 31, 2026.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
- The report was signed by Brett Hale, who serves as Chief Administrative Officer, CFO, Treasurer, and Corporate Secretary.
Hyperfine, Inc. entered into a $40 million senior secured term loan facility with Horizon Technology Finance Corporation, drawing an initial $15 million. The agreement includes the issuance of warrants for over 1 million shares and carries a minimum interest rate of 10.75%.
🚩 Red Flags
- High cost of capital with a minimum interest rate of 10.75%.
- Significant back-end fee of 5% of the total principal amount.
- Substantial asset encumbrance, including future liens on intellectual property.
- Dilutive impact from warrants to purchase up to 1,083,335 shares.
📋 Key Facts
- Senior secured term loan facility of up to $40.0 million with Horizon Technology Finance Corporation.
- Initial $15.0 million borrowed on the March 18, 2026 closing date.
- Interest rate is Prime plus 4.25%, with a minimum floor rate of 10.75%.
- Interest-only payment period for 48 months, potentially extending to the March 18, 2031 maturity date if milestones are met.
- Issued warrants for 562,500 shares initially and 520,835 shares contingent on future draws, all at an exercise price of $1.20 per share.
- A final payment fee of 5.0% of the aggregate original principal amount is due upon loan maturity or payoff.
- Loan is secured by substantially all assets, with intellectual property to be included as collateral upon future funding tranches.
Hyperfine, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The filing includes a press release providing a business update and detailed financial performance for the period.
📋 Key Facts
- The report was filed on March 18, 2026, covering the period ending December 31, 2025.
- The company furnished its earnings press release as Exhibit 99.1 under Item 2.02.
- The filing was signed by Brett Hale, who serves as Chief Administrative Officer, Chief Financial Officer, Treasurer, and Corporate Secretary.
- Hyperfine is classified as an emerging growth company.
Hyperfine, Inc. released preliminary unaudited financial results for the quarter and fiscal year ended December 31, 2025, alongside an updated investor presentation.
🚩 Red Flags
- Preliminary figures are unaudited and subject to change upon completion of the annual audit.
📋 Key Facts
- Estimated total revenue for Q4 2025: approximately $5.3 million.
- Estimated total revenue for FY 2025: approximately $13.5 million.
- Estimated cash and cash equivalents as of Dec 31, 2025: approximately $35.1 million.
- The company issued an updated Investor Presentation on January 12, 2026.
Hyperfine, Inc. entered into an amended and restated At-the-Market (ATM) sales agreement to increase its equity offering capacity by $50 million. The amendment adds BTIG, LLC as an additional sales agent alongside B. Riley Securities, Inc.
🚩 Red Flags
- Potential for significant shareholder dilution through the $50M ATM program.
- ATM offerings are often used by micro-cap companies to bolster immediate liquidity, which can signal cash burn concerns (though no explicit going concern was stated in this specific filing).
📋 Key Facts
- Entered into Amended and Restated At Market Issuance Sales Agreement on December 29, 2025.
- Aggregate offering price of up to $50.0 million in Class A common stock.
- Added BTIG, LLC as an additional sales agent; B. Riley Securities remains a participant.
- Sales agents will receive a commission of up to 3.0% of gross sales proceeds.
- The offering is conducted via an existing shelf registration statement on Form S-3.
Hyperfine, Inc. filed an 8-K to announce its third quarter financial results for the period ended September 30, 2025 and provided a general business update.
📋 Key Facts
- Report date: November 13, 2025
- Reporting period: Third Quarter ended September 30, 2025
- The filing includes a press release (Exhibit 99.1) containing financial results and business updates.
- Company is an emerging growth company.
Hyperfine, Inc. entered into an underwriting agreement to conduct a public offering of 14,000,000 shares of Class A common stock at $1.25 per share. The offering is expected to raise approximately $17.5 million in gross proceeds.
🚩 Red Flags
- Significant dilution: Issuance of 14 million new shares at a low price point ($1.25) will result in substantial dilution for existing shareholders.
- Capital raise necessity: The scale of the offering suggests a need for immediate liquidity to fund operations or debt obligations.
📋 Key Facts
- Offering size: 14,000,000 firm shares plus a 30-day option for the underwriter to purchase up to 2,100,000 additional shares.
- Offering price: $1.25 per share.
- Expected gross proceeds: Approximately $17.5 million (before discounts and expenses).
- Underwriter: Lake Street Capital Markets, LLC.
- Underwriting discount: 7.0% on the first $10 million; 6.0% on amounts exceeding $10 million.
- Lock-up period: Directors and executive officers are prohibited from selling securities for 60 days following the agreement date.
- Market prohibition: The company is restricted from issuing or announcing further equity issuances for 90 days.
Hyperfine, Inc. released preliminary unaudited financial results for the third quarter of 2025, reporting estimated revenue of $3.4 million and cash reserves of approximately $21.6 million. The company also highlighted commercial momentum regarding its next-generation Swoop system and Optive AI software.
🚩 Red Flags
- Preliminary financial data is unaudited and subject to change; management notes changes could be material.
📋 Key Facts
- Estimated total revenue for Q3 2025: ~$3.4 million.
- Estimated cash and cash equivalents as of Sept 30, 2025: ~$21.6 million.
- Successful commercial rollout of next-generation Swoop system powered by Optive AI software.
- Converted entire U.S. hospital pipeline to next-generation Swoop systems.
- Initiated full-scale commercial launch in office settings.
- Commenced commercial rollout of Optive AI software in US, Canada, Australia, and New Zealand.
Hyperfine, Inc. filed an 8-K to announce its second quarter 2025 financial results and provide a general business update. The filing serves as a formal vehicle to furnish the earnings press release dated August 13, 2025.
📋 Key Facts
- Reported date: August 13, 2025
- Reporting period: Second quarter ended June 30, 2025
- The filing includes a press release (Exhibit 99.1) containing results of operations and financial condition.
- Company is an emerging growth company.
Hyperfine, Inc. has successfully regained compliance with Nasdaq's minimum bid price requirement. The company previously received a deficiency notice after its stock closed below $1.00 for 30 consecutive business days.
🚩 Red Flags
- Historical price weakness (stock was trading under $1.00 for a sustained period).
📋 Key Facts
- The Company received a formal letter from Nasdaq on August 6, 2025, confirming it has regained compliance with the Bid Price Requirement.
- Compliance was achieved following a deficiency notice issued on April 30, 2025.
- The deficiency was triggered by the Class A common stock closing below $1.00 for 30 consecutive business days per Nasdaq Listing Rule 5450(a)(1).
- Nasdaq has declared this specific delisting matter closed.
Hyperfine, Inc. announced the resignation of R. Scott Huennekens as Chairperson of the Board and director, effective May 22, 2025. The Board also approved a reduction in its total size from six to five members and appointed Daniel J. Wolterman as the new Chairperson.
🚩 Red Flags
- Reduction in Board size (from 6 to 5) can sometimes signal shifting governance dynamics, though not inherently negative without further context.
📋 Key Facts
- R. Scott Huennekens resigned as Chairperson and Board member effective May 22, 2025.
- The resignation was for personal reasons and not due to any disagreement or dispute with the Company.
- The Board size is being reduced from six members to five members.
- Daniel J. Wolterman has been appointed as the new Chairperson of the Board.
Hyperfine, Inc. held its 2025 annual meeting of stockholders on May 19, 2025. The company successfully reelected six members to its Board of Directors and ratified the appointment of Grant Thornton LLP as its independent auditor for the upcoming fiscal year.
📋 Key Facts
- Annual Meeting held on May 19, 2025.
- Quorum reached with approximately 90.95% of voting power present (29,880,210 Class A and 15,055,288 Class B shares).
- Six directors reelected: R. Scott Huennekens, Maria Sainz, John Dahldorf, Ruth Fattori, Jonathan M. Rothberg, Ph.D., and Daniel J. Wolterman.
- Grant Thornton LLP ratified as independent registered public accounting firm for the fiscal year ending December 31, 2025.
Hyperfine, Inc. filed an 8-K to announce its financial results for the first quarter ended March 31, 2025, and provided a general business update via press release.
🚩 Red Flags
- None identified in the provided text; this is a standard earnings release filing.
📋 Key Facts
- Reporting period: First Quarter ended March 31, 2025
- Filing date: May 13, 2025
- The filing includes results of operations and financial condition updates (Item 2.02).
- Company is classified as an emerging growth company.
Hyperfine, Inc. received a notice from Nasdaq stating it is non-compliant with the minimum bid price requirement after its stock closed below $1.00 for 30 consecutive business days. The company has until October 27, 2025, to regain compliance or face potential delisting.
🚩 Red Flags
- Delisting notice from Nasdaq
- Stock price sustained below $1.00 (Penny stock territory)
- Explicit mention of potential reverse stock split as a cure mechanism
📋 Key Facts
- Received written notice from Nasdaq on April 30, 2025.
- Non-compliance due to Class A common stock closing bid price falling below $1.00 for 30 consecutive business days (Nasdaq Listing Rule 5450(a)(1)).
- Initial compliance period of 180 calendar days granted, expiring October 27, 2025.
- To regain compliance, the stock must close at $1.00 or higher for at least 10 consecutive business days.
- Potential for a second 180-day extension involving a transfer to Nasdaq Capital Market and potentially implementing a reverse stock split.
Hyperfine, Inc. filed an 8-K to furnish its press release announcing financial results for the fourth quarter and full year ended December 31, 2024.
📋 Key Facts
- Reporting period: Fourth quarter and fiscal year ended December 31, 2024.
- Filing date: March 17, 2025.
- The filing includes a business update alongside the financial results via Exhibit 99.1.
Hyperfine, Inc. entered into a securities purchase agreement to conduct a registered direct offering of 4,511,278 shares of Class A common stock and an equal number of warrants at $1.33 per unit. The gross proceeds are expected to be approximately $6.0 million.
🚩 Red Flags
- Significant dilution: The issuance of warrants equal to the number of shares sold creates substantial potential future dilution.
- Warrant overhang: Warrants are immediately exercisable, which can create downward selling pressure upon exercise.
- Small offering size: $6M gross proceeds is relatively small for a public company, suggesting limited access to larger capital markets.
📋 Key Facts
- Offering size: 4,511,278 shares of Common Stock and 4,511,278 Warrants.
- Combined offering price: $1.33 per share/warrant unit.
- Expected gross proceeds: ~$6.0 million (before fees).
- Warrants are immediately exercisable at $1.33 and expire in 5 years.
- Placement Agent: Lake Street Capital Markets, LLC (7.0% fee + expenses up to $160,000).
- The company expects the net proceeds to extend its cash runway until the end of 2026.
Hyperfine, Inc. updated its corporate presentation to include preliminary unaudited financial results for the fiscal year ended December 31, 2024. The company also reported several operational milestones achieved in Q4 2024 related to regulatory approvals and market expansion.
🚩 Red Flags
- Preliminary financial data is unaudited and subject to change; management notes changes could be material.
📋 Key Facts
- Estimated FY2024 total revenue: ~$12.9 million (Device: $10.5M; Service: $2.4M).
- Estimated FY2024 gross margin: approximately 46%.
- Estimated cash and cash equivalents as of Dec 31, 2024: ~$37.6 million.
- Received IAC accreditation for ultra-low-field MRI technology, enabling CMS reimbursement in the US.
- Obtained CE approval for 9th generation AI-powered brain imaging software with four European language configurations.
- Expanded distribution network to 13 partners by end of 2024.
Hyperfine, Inc. has implemented an organizational restructuring involving the termination of approximately 14% of its global workforce to streamline operations as it transitions from development to commercial stage. The company expects to incur up to $0.4 million in restructuring costs and aims to extend its cash runway into the second half of 2026.
🚩 Red Flags
- Significant workforce reduction (14%) indicates cost-cutting measures typical of companies managing liquidity constraints.
- The need to extend cash runway suggests previous burn rates were unsustainable or capital was insufficient for the prior trajectory.
📋 Key Facts
- Terminated approximately 14% of global workforce on January 28, 2025.
- Restructuring primarily affects technical and internally-facing roles.
- Estimated restructuring costs: up to $0.4 million (severance and related benefits).
- Expected completion of restructuring: Q1 2025.
- Updated cash runway guidance: operations expected to continue into the second half of 2026.
- Company has received nine generations of FDA clearances for Swoop® system software to date.
Hyperfine, Inc. filed an 8-K to announce its third quarter 2024 financial results and provide a general business update as of November 12, 2024.
📋 Key Facts
- Report covers the third quarter ended September 30, 2024.
- The filing includes a press release (Exhibit 99.1) containing results of operations and financial condition.
- Company is an emerging growth company.
Hyperfine, Inc. filed an 8-K to announce its second quarter 2024 financial results and provide a general business update. The filing serves as a formal mechanism to furnish the earnings press release dated August 8, 2024.
📋 Key Facts
- Reporting period: Second Quarter ended June 30, 2024.
- Filing date: August 8, 2024.
- The filing includes a press release (Exhibit 99.1) detailing results of operations and financial condition.
- Company is an emerging growth company.
Hyperfine, Inc. has regained compliance with Nasdaq's minimum bid price requirement after its stock had fallen below $1.00 for 30 consecutive business days. The matter regarding the potential delisting notice received on May 29, 2024, is now officially closed.
🚩 Red Flags
- Historical price volatility: The stock previously triggered a deficiency notice due to falling below $1.00 for 30 consecutive business days.
📋 Key Facts
- The company was previously notified on May 29, 2024, that it failed to meet Nasdaq's $1.00 minimum bid price requirement (Nasdaq Listing Rule 5450(a)(1)).
- As of July 24, 2024, the company received confirmation from Nasdaq Staff that it has regained compliance.
- The delisting matter is officially considered closed by the exchange.
Hyperfine, Inc. reported the results of its 2024 annual meeting of stockholders held on June 11, 2024. The meeting resulted in the reelection of six directors, the ratification of Grant Thornton LLP as independent auditors, and the approval of a charter amendment regarding the automatic conversion of Class B common stock.
📋 Key Facts
- Annual Meeting held on June 11, 2024, with 92.45% of voting power represented in attendance.
- Six nominees (R. Scott Huennekens, Maria Sainz, John Dahldorf, Ruth Fattori, Jonathan M. Rothberg, and Daniel J. Wolterman) were reelected to the Board of Directors.
- Grant Thornton LLP was ratified as the independent registered public accounting firm for fiscal year ending Dec 31, 2024.
- Stockholders approved a Charter Amendment providing for the automatic conversion of Class B common stock effective December 22, 2028.
Hyperfine, Inc. received a notice from Nasdaq stating it is in violation of the minimum bid price requirement after its stock closed below $1.00 for 30 consecutive business days. The company has until November 25, 2024, to regain compliance.
🚩 Red Flags
- Delisting notice (non-compliance with minimum bid price requirement)
- Stock price has been consistently below $1.00 for 30 consecutive business days
- Risk of delisting if compliance is not met by November 25, 2024
📋 Key Facts
- Received written notice from Nasdaq on May 29, 2024.
- Violation of Nasdaq Listing Rule 5450(a)(1) due to closing bid price falling below $1.00 for 30 consecutive business days.
- Initial compliance period expires November 25, 2024.
- To regain compliance, the stock must close at or above $1.00 for at least 10 consecutive business days.
- The company may be eligible for an additional 180-day extension if it transfers to the Nasdaq Capital Market and meets other requirements.
Hyperfine, Inc. filed an 8-K to announce its financial results for the first quarter ended March 31, 2024, and provided a general business update via press release.
📋 Key Facts
- Reporting period: First Quarter ended March 31, 2024.
- Filing date: May 13, 2024.
- The filing includes an earnings press release (Exhibit 99.1) regarding results of operations and financial condition.
Hyperfine, Inc. filed an 8-K to furnish its press release announcing financial results for the fourth quarter and full year ended December 31, 2023.
📋 Key Facts
- Report date: March 21, 2024
- Reporting period: Fourth quarter and fiscal year ended December 31, 2023
- The filing is a standard earnings release under Item 2.02
- Company is an emerging growth company